publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 Generic Name Brand Name Manufacturer Indication(s) Month Approved*...

Configure the table properties Cellular and gene therapy and biosimilar approvals Oncology drug approvals - 2026 None Configure the table properties Specialty drug approvals Traditional drug...

Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax....

AMCP 2026 spotlighted oncology innovation, AI, and payer strategies, with KOL insights on cost, access, and evolving managed care trends.

Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event

9 Comprehensive outcomes reporting Insert Link Learn more about cystic fibrosis We support members navigating their cystic fibrosis (CF) with a holistic, customized approach to care. Tab 1 Holistic...

$3,413 Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing strategies, for all lines of business. When...

Connect care for your members with cancer Home Our solutions Specialty drug management IntegratedRx IntegratedRx - Oncology Reducing the risk of major side effects IntegratedRx® streamlines the...